Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXRNASDAQ:ECORNASDAQ:INBSNASDAQ:MDAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$8.10-0.4%$7.71$6.55▼$10.00$39.18M-0.216,087 shs2,768 shsECORelectroCore$5.08+3.7%$5.93$4.47▼$19.49$37.70M0.9294,260 shs68,392 shsINBSIntelligent Bio Solutions$1.44-3.4%$1.31$1.00▼$3.00$9.95M4.63552,424 shs82,299 shsMDAISpectral AI$1.60-3.5%$1.30$0.82▼$3.25$40.55M0.59841,862 shs97,761 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor0.00%+4.65%+7.57%+5.19%-7.53%ECORelectroCore0.00%+2.21%-25.84%-65.47%-21.00%INBSIntelligent Bio Solutions0.00%+2.13%+5.88%-30.77%-38.72%MDAISpectral AI0.00%+9.71%+26.12%+0.74%-3.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDXRDaxor3.7305 of 5 stars3.53.00.00.02.03.30.0ECORelectroCore2.6931 of 5 stars3.52.00.00.03.12.50.6INBSIntelligent Bio Solutions0.3633 of 5 stars0.02.00.00.02.80.00.6MDAISpectral AI2.6652 of 5 stars3.72.00.00.02.93.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXRDaxor 3.00Buy$25.00208.64% UpsideECORelectroCore 3.00Buy$25.50401.97% UpsideINBSIntelligent Bio Solutions 0.00N/AN/AN/AMDAISpectral AI 3.33Buy$4.75196.56% UpsideCurrent Analyst Ratings BreakdownLatest INBS, DXR, MDAI, and ECOR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/18/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/17/2025DXRDaxorAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$24.75 ➝ $25.003/13/2025ECORelectroCoreLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $26.003/13/2025ECORelectroCoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXRDaxor$2.13M18.39N/AN/AN/A∞ECORelectroCore$26.46M1.42N/AN/A$1.24 per share4.10INBSIntelligent Bio Solutions$2.94M3.39N/AN/A$0.80 per share1.80MDAISpectral AI$29.96M1.35N/AN/A($0.10) per share-16.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AECORelectroCore-$18.83M-$1.56N/AN/AN/A-54.40%-154.45%-69.16%8/6/2025 (Estimated)INBSIntelligent Bio Solutions-$10.16MN/A0.004.11N/A-323.79%-146.03%-83.62%N/AMDAISpectral AI-$20.85M-$0.54N/AN/AN/A-40.78%N/A-77.87%N/ALatest INBS, DXR, MDAI, and ECOR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million3/27/2025Q4 2024MDAISpectral AI-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDXRDaxor$0.030.37%N/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXRDaxorN/AN/AN/AECORelectroCoreN/A2.121.87INBSIntelligent Bio SolutionsN/A0.920.76MDAISpectral AIN/A0.730.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXRDaxor1.34%ECORelectroCore26.74%INBSIntelligent Bio Solutions32.97%MDAISpectral AI67.08%Insider OwnershipCompanyInsider OwnershipDXRDaxor59.00%ECORelectroCore19.70%INBSIntelligent Bio Solutions1.54%MDAISpectral AI30.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXRDaxor374.84 million1.98 millionNot OptionableECORelectroCore507.42 million5.35 millionNot OptionableINBSIntelligent Bio Solutions106.91 million5.26 millionNot OptionableMDAISpectral AI8325.32 million8.04 millionNot OptionableINBS, DXR, MDAI, and ECOR HeadlinesRecent News About These CompaniesSpectral AI Announces Appointment of Stanley Micek as Chief Operating OfficerMay 30 at 8:00 AM | globenewswire.comSpectral AI Announces Voting Results from 2025 Annual Meeting of StockholdersMay 29, 2025 | globenewswire.comDeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns JournalMay 27, 2025 | finance.yahoo.comBrokers Issue Forecasts for Spectral AI Q2 EarningsMay 24, 2025 | americanbankingnews.comSpectral AI, Inc. (MDAI) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comSpectral AI Announces 2025 First Quarter Financial ResultsMay 13, 2025 | globenewswire.comWhat's Next: Spectral AI's Earnings PreviewMay 12, 2025 | benzinga.comBurn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meetingApril 30, 2025 | finance.yahoo.comBurn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meetingApril 30, 2025 | globenewswire.comSpectral AI files to sell 2.84M shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comGlobal AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic CollaborationsApril 16, 2025 | markets.businessinsider.comSpectral AI (MDAI) Secures $17.7 Million to Launch Burn Wound AI SystemApril 1, 2025 | msn.comSpectral AI Inc. (MDAI) Poised for FDA Approval with Revolutionary DeepView SystemMarch 30, 2025 | msn.comSpectral AI, Inc. (NASDAQ:MDAI) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | msn.com10 AI Stocks Dominating the News This WeekMarch 28, 2025 | insidermonkey.comTop 8 AI News Updates Investors Should Not MissMarch 28, 2025 | insidermonkey.comSpectral AI reports Q4 EPS (41c) vs. (22c) last yearMarch 28, 2025 | markets.businessinsider.comSpectral AI, Inc. (MDAI) Q4 2024 Earnings Call TranscriptMarch 27, 2025 | seekingalpha.comSpectral AI Announces 2024 Fourth Quarter and Full Year Financial ResultsMarch 27, 2025 | globenewswire.comSpectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. CommercializationMarch 24, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINBS, DXR, MDAI, and ECOR Company DescriptionsDaxor NASDAQ:DXR$8.10 -0.03 (-0.37%) As of 05/30/2025 12:29 PM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.electroCore NASDAQ:ECOR$5.08 +0.18 (+3.67%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$5.00 -0.08 (-1.57%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Intelligent Bio Solutions NASDAQ:INBS$1.44 -0.05 (-3.36%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.41 -0.03 (-2.08%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Spectral AI NASDAQ:MDAI$1.60 -0.06 (-3.51%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.60 0.00 (-0.11%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
